http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-329327-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6957040cd6075e8cdf2616604541e93f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
filingDate 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f209cd9214eedd06cf4b81e596b87827
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_545fe77bf90a3e96eeda5689cd26c23f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_564dde70ca2360b261d8f11a12a72272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a442bca3fab644518a1d96d315788ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7994a5c177aef9fc9b265ed6910273c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf813d5150647b50079b7577eee643da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06a710272e3f803c2ff02e33f9f908b6
publicationDate 2010-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-329327-B1
titleOfInvention Polymorph of 4- [2- [4- [1- (2-ethoxyethyl) -1H-benzimidazol-2-yl] -1-piperidinyl] ethyl] -β, β-dimethylbenzeneacetic acid containing said polymorph, and its use
abstract Polymorph I of 4- [2- [4- [1- (2-ethoxyethyl) -1H-benzimidazol-2-yl] -1-piperidinyl] ethyl] - (α, α-dimethylbenzeneacetic acid of formula (I) is described, as well as procedures for its preparation, pharmaceutical formulations containing polymorph I and the use of polymorph I to treat allergic reactions and pathological processes mediated by histamine in mammals such as humans.
priorityDate 2002-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13222
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421272584
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898

Total number of triples: 34.